Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 700 Million | USD 1319 Million | 9.3% | 2021 |
The global Anti-biofilm Wound Dressing Market accrued earnings worth approximately 700 (USD Million) in 2021 and is predicted to gain revenue of about 1,319 (USD Million) by 2028, is set to record a CAGR of nearly 9.3% over the period from 2022 to 2028. The report offers an assessment and analysis of the Anti-biofilm Wound Dressing Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Million).
Anti-biofilm activities can modify bacterial diversity through interferences between bacteria and host surface. Various kinds of action mechanisms can explain chain reaction resulting in anti-biofilm processes. Moreover, nearly 80% of microbial biomass is found in biofilm state and hence anti-biofilm wound dressing is most preferred choice of medical practitioners. Surging number of cancer patients & diabetics has resulted in need for treating their wounds with anti-biofilm wound dressing, thereby culminating into tremendous market demand. Reportedly, anti-biofilms are derived from natural plants and its formation is for purpose of suppressing microbial adhesion.
Growth of anti-biofilm wound dressing market over forecast timespan can be credited to rise in occurrence of diabetics across globe. In addition to this, increase in road collisions, trauma accidents, and wound burns will cascade elevation of size of anti-biofilm wound dressing market. Furthermore, its use in treating chronic wounds will catalyze expansion of anti-biofilm wound dressing industry. Its growing application in food & biomedical sectors will float market revenue. Its antiseptic & antifungal properties have helped in quick recovery of patients suffering from chronic wounds.
Moreover, iodine based anti-biofilm wound dressing is utilized for reducing spread of wound infection. With outbreak of COVID-19 pandemic, patients affected due to wounds were either treated at homes or outpatient clinics. All these aspects will generate new avenues of growth for anti-biofilm wound dressing market and explore new facades of expansion across globe. Reportedly, large numbers of post-cancer surgeries is very deep and require routine management & treatment of wounds. This will increase product penetration in medical care sector, thereby driving market size.
Report Attributes | Report Details |
---|---|
Report Name | Anti-biofilm Wound Dressing Market Size Report |
Market Size in 2021 | USD 700 Million |
Market Forecast in 2028 | USD 1319 Million |
Growth Rate | CAGR of 9.3% |
Number of Pages | 188 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Molnlycke Healthcare, BioMonde, B. Braun Melsungen AG, Monarch Labs, Next Science Company, The 3M Company, Coloplast A/S, Urgo Medical, Smith & Nephew PLC, and ConvaTec Group plc |
Segments Covered | By Application, By Mode of Mechanism, By End-User, and By Region |
Base Year | 2021 |
Historical Year | 2015 to 2020 |
Forecast Year | 2021 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific Market To Register Fastest Growth Over 2022-2028
Expansion of anti-biofilm wound dressing market in Asia Pacific over next six years can be credited to surge in sports injuries, road collisions, and presence of giant manufacturers in sub-continent. Apart from this, easy availability of strong healthcare infrastructure facility in countries such as Japan, South Korea, Vietnam, Thailand, and China will multiply growth volume of anti-biofilm wound dressing market in Asia Pacific. Thriving medical tourism activities in India, Indonesia, Philippines, and Thailand will further contribute to regional market size.
By Application
By Mode of Mechanism
By Region
FrequentlyAsked Questions
Growth of Anti-biofilm Wound Dressing Market Size over forecast timespan can be attributed to surge in rise in occurrence of diabetics across globe.
According to Zion market research report, the global Anti-biofilm Wound Dressing Market Size accrued earnings worth approximately 700 (USD Million) in 2021 and is predicted to gain revenue of about 1,319 (USD Million) by 2028, is set to record a CAGR of nearly 9.3% over the period from 2022 to 2028.
Asia Pacific will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to surge in sports injuries, road collisions, and presence of giant manufacturers in sub-continent.
The key market participants include Molnlycke Healthcare, BioMonde, B. Braun Melsungen AG, Monarch Labs, Next Science Company, The 3M Company, Coloplast A/S, Urgo Medical, Smith & Nephew PLC, and ConvaTec.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed